TRANSLATIONAL MEDICINE & USE OF BIOMARKERS

ADESTE STUDY

A Dose Escalation Evaluation of Safety and Tolerability of Adrecizumab – a Humanized Monoclonal Antibody against Adrenomedullin (ADM) in Patients with Acute Heart Failure Requiring Hospitalization.

Adrecizumab Dose Escalation Safety and Tolerability Evaluation.

BRAVA STUDY

Biomarker Rule in/out in patients with Acute diseases for Validation of Acute kidney injury: Prospective observational study on AKI detection in the Emergency Department: The role of NephroCheck.
The potential role of biomarkers (NephroCheck) in determining the incidence of acute kidney injury (AKI) in all-comers patients presenting to the Emergency Department with acute diseases.